It sure would be awesome if a combination of two old, cheap, generic drugs were a magic bullet, but will it be? I am getting mixed feedback from friends in health professions.
One (an advanced practice nurse) forwarded me a journal article that was released today - unfortunately I haven’t found the article itself online yet - and said some of her friends have already started using the protocol when warranted. The other (a pharmacist) says the journal results aren’t really that great, but it’s full of medical jargon that I need to read again tomorrow with a clear head. Here’s what the article’s authors say (in French - my crappy translation to follow):
Marseille, March 22, 2020
Covid-19 coronavirus outbreak
In the current context of the spread of the Covid-19 coronavirus epidemic on French territory and worldwide. In accordance with the Hippocratic Oath that we have taken, we obey our duty as doctors. We provide our patients with the best care for the diagnosis and treatment of a disease. We respect the rules of the art and the most recently acquired data of medical science.
We have decided:
· For all febrile patients who come to consult us, to carry out tests to diagnose Covid 19 infection;
-
For all infected patients who have lung lesions on CT scan, many of whom are not very symptomatic, to propose as soon as possible, as soon as the diagnosis is made:
-
a treatment with a combination of hydroxychloroquine (200 mg x 3 per day for 10 days) + Azithromycin (500 mg on the 1st day then 250 mg per day for 5 more days), as part of the precautions for use of this association (including an electrocardiogram on D0 and D2), and outside of marketing authorization [off-label use? my medical French is not so fabulous. If yours is better, please elaborate]. In cases of severe pneumonia, a broad-spectrum antibiotic is also used.
We believe that it is unethical not to systematically include this combination in therapeutic trials for the treatment of Covid-19 infection in France.
Pr Philippe Brouqui, Pr Jean-Christophe Lagier, Pr Matthieu Million, Pr Philippe Parola, Pr Didier Raoult, Dr Marie Hocquart
Meanwhile, the pharmacist friend is already getting people bringing in questionable prescriptions for this therapy written by doctors in unrelated specialties, and is really pissed off, because of course that means the drugs are already backordered and not available to people who need them for COVID-19 or any other reason.
Any medical professionals care to comment on the validity of the study? Any French speakers want to correct my translation? Has anyone seen the actual study published online anywhere? (I have a .pdf copy.) Does anyone care to comment on the medical ethics of trying an off-label use in a situation like this?
In what situations is it warranted to try an unproven treatment?
(The draft of the article that I have is Gautret et al. (2020) Hydroxychloroquine and azithromycin as a treatment of COVID-19, International Journal of Microbial Agents. I think it’s a draft because it still has a bunch of typos and minor grammatical errors.)